ストックスクリーナーアプリを入手
1.19
4.03%
-0.05
アフターアワーズ：
1.22
0.03
+2.52%
前日終値:
$1.24
開ける：
$1.22
24時間の取引高:
166.57K
Relative Volume:
0.58
時価総額：
$61.64M
収益：
-
当期純損益:
$-56.85M
株価収益率:
-0.7633
EPS:
-1.559
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-8.46%
1か月 パフォーマンス:
-23.72%
6か月 パフォーマンス:
-52.96%
1年 パフォーマンス:
-83.92%
1日の値動き範囲:
$1.15
$1.2329
1週間の範囲:
$1.15
$1.325
52週間の値動き範囲:
$1.15
$7.89
Fractyl Health Inc Stock (GUTS) Company Profile
GUTS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
1.19 | 61.64M | 0 | -56.85M | 0 | -1.559 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-02-28 | 開始されました | Evercore ISI | Outperform |
| 2024-02-27 | 開始されました | BofA Securities | Buy |
| 2024-02-27 | 開始されました | Morgan Stanley | Overweight |
Fractyl Health Inc (GUTS) 最新ニュース
Fractyl Health, Inc. (NASDAQ:GUTS) Shares Acquired by Bank of New York Mellon Corp - Defense World
Fractyl Health director Barnes acquires $40,210 in common stock - Investing.com India
Fractyl Health director Ajay Royan purchases $22,979 in common stock By Investing.com - Investing.com Australia
Fractyl Health director Ajay Royan purchases $22,979 in common stock - Investing.com India
FRACTYL HEALTH Executives Increase Their Stakes - TradingView
Fractyl Health director Barnes acquires $40,210 in common stock By Investing.com - Investing.com UK
FRACTYL HEALTH Director Bradley William Acquires 16,129 Shares - TradingView
Fractyl Health sets June 11 for 2025 stockholder meeting - Investing.com
Fractyl Health sets June 11 for 2025 stockholder meeting By Investing.com - Investing.com South Africa
Rhumbline Advisers Boosts Stock Holdings in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Spotlight On Fractyl Health And Two Other Intriguing Penny Stocks - Yahoo Finance
Fractyl Health Reports 2024 Financial Results and Strategic Progress - MSN
Earnings call transcript: Fractyl Health’s Q4 2024 results miss expectations, stock drops - Investing.com India
FRACTYL HEALTH Earnings Results: $GUTS Reports Quarterly Earnings - Nasdaq
Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates - TradingView
Fractyl Health Highlights Urgent Demand for Weight Maintenance Solutions Post-GLP-1 Therapy in Upcoming REMAIN-1 Study Amid Strategic Focus on Metabolic Health - Nasdaq
Fractyl's Weight Maintenance Study Hits 189 Patients: Can It Solve the GLP-1 Rebound Problem? - StockTitan
Earnings Scheduled For March 3, 2025 - Benzinga
Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025 - The Manila Times
Fractyl Health to Report Fourth Quarter and Full Year 2024 - GlobeNewswire
Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide ... - The Bakersfield Californian
Can This Metabolic Disease Pioneer Deliver Strong Q4 Results? Fractyl Health Reports March 3 - StockTitan
Fractyl Health, Inc. (NASDAQ:GUTS) Sees Significant Drop in Short Interest - MarketBeat
Stratos Wealth Partners LTD. Sells 21,148 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
After Plunging -19.55% in 4 Weeks, Here's Why the Trend Might Reverse for Fractyl Health, Inc. (GUTS) - Yahoo Finance
Beyond GLP-1s? This biotech is exploring longer-term metabolic treatments - PharmaVoice
Insider Selling: Fractyl Health, Inc. (NASDAQ:GUTS) CEO Sells 90,972 Shares of Stock - MarketBeat
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Fractyl Health (NASDAQ:GUTS) Price Target Cut to $10.00 by Analysts at Morgan Stanley - MarketBeat
Potential Price Increase for Fractyl Health Inc (GUTS) After Recent Insider Activity - Knox Daily
BlackRock, Inc. Increases Stake in Fractyl Health Inc: A Strategic Move in Biotechnology - GuruFocus.com
Fractyl Health, Inc. (NASDAQ:GUTS) Stock Position Lifted by JPMorgan Chase & Co. - Defense World
Fractyl Health, Inc. (NASDAQ:GUTS) Insider Jay David Caplan Sells 22,346 Shares - MarketBeat
Fractyl Health Inc (GUTS) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
Trading Day Triumph: Fractyl Health Inc (GUTS) Ends at 1.70, a -7.61 Surge/Plunge - The Dwinnex
Fractyl Health (NASDAQ:GUTS) Given New $10.00 Price Target at Morgan Stanley - Defense World
FRACTYL HEALTH Executives Sell Shares - TradingView
Fractyl Health announces layoffs as it pivots to gene therapy - Mass Device
Burlington biotech company announces layoffs, pivots research focus - NBC Boston
Fractyl Health Announces Increased Focus on Groundbreaking - GlobeNewswire
Fractyl Health pivots Type 2 diabetes device therapy toward obesity and GLP-1s, lays off 17% of staff - Fierce Biotech
Fractyl Health To Focus On Revita, Rejuva Programs, To Cut Workforce By 17%; Stock Down - Nasdaq
Fractyl Health announces increased focus on Revita, Rejuva programs - TipRanks
Fractyl Health Reprioritizes Focus on REMAIN-1 Study - TipRanks
Fractyl Health Prioritizes Clinical Development of Revita and Advances Rejuva Gene Therapy in Response to Market Demand - Nasdaq
Fractyl Health Announces Increased Focus on Groundbreaking Revita® Weight Maintenance and Rejuva® Pancreatic Gene Therapy Programs with Potential to Deliver Key Clinical Milestones Across Multiple Studies in 2025 - Yahoo Finance
Burlington biotech slims down 17% of workforce, focuses on weight maintenance treatment - The Business Journals
Barclays PLC Grows Position in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Fractyl Health, Inc. (NASDAQ:GUTS) Sees Large Growth in Short Interest - MarketBeat
Head-To-Head Analysis: Tactile Systems Technology (NASDAQ:TCMD) and Fractyl Health (NASDAQ:GUTS) - Defense World
Fractyl Health Inc (GUTS) 財務データ
収益
当期純利益
現金流量
EPS
1.05%
1.79%
大文字化:
|
ボリューム (24 時間):